FI902291A0 - Heterocykliska guanider som 5ht3 -antagonister. - Google Patents

Heterocykliska guanider som 5ht3 -antagonister.

Info

Publication number
FI902291A0
FI902291A0 FI902291A FI902291A FI902291A0 FI 902291 A0 FI902291 A0 FI 902291A0 FI 902291 A FI902291 A FI 902291A FI 902291 A FI902291 A FI 902291A FI 902291 A0 FI902291 A0 FI 902291A0
Authority
FI
Finland
Prior art keywords
methyl
carbon atoms
guanider
antagonister
heterocycliska
Prior art date
Application number
FI902291A
Other languages
English (en)
Finnish (fi)
Inventor
Arthur Adam Nagel
James Patrick Rizzi
Terry Jay Rosen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI902291A0 publication Critical patent/FI902291A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
FI902291A 1989-05-19 1990-05-08 Heterocykliska guanider som 5ht3 -antagonister. FI902291A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,189 US4963689A (en) 1989-05-19 1989-05-19 Heterocyclicguanidines as 5HT3 antagonists

Publications (1)

Publication Number Publication Date
FI902291A0 true FI902291A0 (fi) 1990-05-08

Family

ID=23371270

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902291A FI902291A0 (fi) 1989-05-19 1990-05-08 Heterocykliska guanider som 5ht3 -antagonister.

Country Status (19)

Country Link
US (1) US4963689A (pt)
EP (1) EP0397364B1 (pt)
JP (1) JPH0635454B2 (pt)
KR (1) KR920003927B1 (pt)
AT (1) ATE92062T1 (pt)
AU (1) AU615385B2 (pt)
CA (1) CA2016182C (pt)
DE (1) DE69002384T2 (pt)
DK (1) DK0397364T3 (pt)
ES (1) ES2058795T3 (pt)
FI (1) FI902291A0 (pt)
HU (1) HUT58063A (pt)
IE (1) IE62935B1 (pt)
IL (1) IL94254A (pt)
MY (1) MY105555A (pt)
NO (1) NO902029L (pt)
NZ (1) NZ233576A (pt)
PT (1) PT93979B (pt)
ZA (1) ZA903478B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140034A (en) * 1989-03-14 1992-08-18 Merck Sharp & Dohme Ltd. Five-membered ring systems with bonded imidazolyl ring substituents
US5565479A (en) * 1992-09-14 1996-10-15 Yamanouchi Pharmaceutical Co., Ltd. Condensed thiazole derivative, production process thereof and pharmaceutical composition thereof
WO1995024399A1 (fr) * 1994-03-11 1995-09-14 Yamanouchi Pharmaceutical Co., Ltd. Agoniste de recepteur 5-ht3, nouveau derive de thiazole et intermediaire destine a son obtention
US5887415A (en) * 1995-05-11 1999-03-30 Bernard Matthews Plc Cooked, extruded meat product comprising additive
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
DE102005027193A1 (de) * 2005-06-06 2006-12-07 Wilhelm Stahlecker Gmbh Zwillingseinheit mit zwei Streckwerken für eine Spinnmaschine
ES2664599T3 (es) 2009-05-20 2018-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistas del receptor 5-HT3 de serotonina para uso en el tratamiento de trastornos vestibulares lesionales
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1031165A (en) * 1965-08-18 1966-05-25 Wellcome Found Guanidines, isoureas and isothioureas
GB1305549A (pt) * 1969-10-29 1973-02-07
DE2739723A1 (de) * 1977-09-03 1979-03-08 Merck Patent Gmbh 2-guanidinomethyl-indoline und verfahren zu ihrer herstellung
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds

Also Published As

Publication number Publication date
NO902029D0 (no) 1990-05-08
KR920003927B1 (ko) 1992-05-18
ZA903478B (en) 1991-12-24
NZ233576A (en) 1991-06-25
IE62935B1 (en) 1995-03-08
CA2016182C (en) 1996-03-12
US4963689A (en) 1990-10-16
HU902976D0 (en) 1990-09-28
ES2058795T3 (es) 1994-11-01
PT93979B (pt) 1996-11-29
DK0397364T3 (da) 1993-09-27
IE901664L (en) 1990-11-09
ATE92062T1 (de) 1993-08-15
NO902029L (no) 1990-11-12
JPH0635454B2 (ja) 1994-05-11
DE69002384T2 (de) 1993-11-18
PT93979A (pt) 1991-01-08
CA2016182A1 (en) 1990-11-09
HUT58063A (en) 1992-01-28
JPH0311070A (ja) 1991-01-18
KR900018054A (ko) 1990-12-20
EP0397364A1 (en) 1990-11-14
IL94254A (en) 1994-05-30
MY105555A (en) 1994-10-31
AU615385B2 (en) 1991-09-26
AU5476790A (en) 1990-11-15
DE69002384D1 (de) 1993-09-02
EP0397364B1 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
CA2084193A1 (en) 3-amino-2-aryl quinuclidines
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
EA200401381A1 (ru) 3-гетероарилзамещённые изоксазолины
DE60011895D1 (de) Heterocyclische subtituierte aminoazacyclische verbindungen mit zentraler nervensystemwirkung
ATE102197T1 (de) Arylthiazolylimidazole als 5ht3-antagonisten.
FI902291A0 (fi) Heterocykliska guanider som 5ht3 -antagonister.
DK671688A (da) 2-(piperazinyl)-2-oxoethylensubstituerede flavonoidderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
FR2672892B1 (fr) Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.
ATE13885T1 (de) Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre herstellung und diese enthaltende therapeutische mittel.
DK0508955T3 (da) Anvendelse af 2-iminothiazolidin-4-onderivater som nye lægemidler
KR910002818A (ko) 4,5,6,7-사치환된 벤즈옥사졸론
TH1357B (th) 2-ออกซ์อินโดล ที่ถูกแทนที่ที่ตำแหน่ง 1 และ 3 ในฐานะสารแก้ปวดและต่อต้านการอักเสบ
AR011139A1 (es) 4-aminoalcoxi-1,3-dihidro-benzoimidazol-2-tionas, su uso en la preparacion de un medicamento y composicion farmaceutica que los contiene

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.